首页> 外文期刊>British journal of anaesthesia >Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting.
【24h】

Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting.

机译:丙泊酚-阿片类药物与异氟烷-阿片类药物麻醉对冠状动脉搭桥术患者术后肌钙蛋白释放的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In experimental and clinical studies, volatile anaesthesia has proven to possess cardioprotective properties. However, no randomized controlled trials on the use of isoflurane during the entire cardiac surgical procedure are available. We therefore compared isoflurane-sufentanil vs propofol-sufentanil anaesthesia in patients undergoing coronary artery bypass grafting. METHODS: One hundred patients were randomly assigned to receive isoflurane-sufentanil (I) (n = 51) or propofol-sufentanil (P) (n = 49) anaesthesia, aimed at the same hypnotic depth. Postoperative concentrations of cardiac troponin I (cTnI) were followed for 72 h. Secondary outcome variables were length of stay (LOS) in the intensive care unit (ICU) and in hospital, and 30 day and 1 yr mortality and morbidity, defined as acute myocardial infarction, arrhythmias, and cardiac dysfunction. Groups were compared by an on-treatment analysis, using linear mixed models for repeated measures. RESULTS: Eighty-four patients completed the protocol (I: 41 vs P: 43). Postoperative cTnI concentrations increased to a maximum of I: 2.72 ng ml(-1) (1.78-5.85) and P: 2.64 ng ml(-1) (1.67-4.83), but did not differ between groups (P=0.11). LOS in the ICU and in hospital was similar [ICU I: 18 (17.0-21.5) vs P: 19 (17.0-22.0) h; hospital I: 9 (6.5-8.0) vs P: 8 (6.0-9.0) days]. Cardiac morbidity and mortality in hospital and 30 days after surgery did not differ between groups. One year after surgery, two patients had died of non-cardiac causes. No between-group differences in cardiac morbidity were found. CONCLUSIONS: In this study, the use of isoflurane-sufentanil in comparison with propofol-sufentanil anaesthesia does not afford additional reduction of postoperative cTnI levels.
机译:背景:在实验和临床研究中,挥发性麻醉已被证明具有心脏保护作用。但是,尚无关于在整个心脏外科手术过程中使用异氟烷的随机对照试验。因此,我们在接受冠状动脉搭桥术的患者中比较了异氟烷-舒芬太尼麻醉与丙泊酚-舒芬太尼麻醉的比较。方法:以相同的催眠深度将一百例患者随机分配接受异氟烷舒芬太尼(I)(n = 51)或丙泊酚舒芬太尼(P)(n = 49)麻醉。术后72小时监测心脏肌钙蛋白I(cTnI)的浓度。次要结果变量为重症监护病房(ICU)和医院的住院时间(LOS),以及30天和1年的死亡率和发病率,定义为急性心肌梗塞,心律不齐和心脏功能障碍。使用线性混合模型进行重复测量,通过治疗分析比较各组。结果:84名患者完成了方案(I:41 vs P:43)。术后cTnI浓度增加到最大I:2.72 ng ml(-1)(1.78-5.85)和P:2.64 ng ml(-1)(1.67-4.83),但两组之间无差异(P = 0.11)。重症监护病房和医院的LOS相似[ICU I:18(17.0-21.5)vs P:19(17.0-22.0)h;医院I:9(6.5-8.0)天与P:8(6.0-9.0)天]。两组之间在医院和手术后30天的心脏发病率和死亡率无差异。手术一年后,有两名患者死于非心脏原因。没有发现心脏发病率的组间差异。结论:在这项研究中,与异丙酚-舒芬太尼麻醉相比,异氟烷-舒芬太尼的使用不能进一步降低术后cTnI水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号